Epogen Use Re-Calculation Drives 9.4% Medicare ESRD Bundled Payment Cut In 2014
This article was originally published in The Pink Sheet Daily
Executive Summary
CMS was directed by the American Taxpayer Relief Act to “rebase” the ESRD payment level by re-calculating the use of erythropoiesis-stimulating agents and other infused or injectable therapies.